Evidence map›Paper›PMID 38179280›Full record

ArticleFrontiers in medicine2023

Machine learning-based clinical decision support for infection risk prediction.

Ting Feng, David P Noren, Chaitanya Kulkarni, Sara Mariani, Claire Zhao, Erina Ghosh, Dennis Swearingen, Joseph Frassica, Daniel McFarlane, Bryan Conroy

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Ting FengPhilips Research North America, Cambridge, MA, United States.
David P NorenPhilips Research North America, Cambridge, MA, United States.
Chaitanya KulkarniPhilips Research Bangalore, Bengaluru, India.
Sara MarianiPhilips Research North America, Cambridge, MA, United States.
Claire ZhaoPhilips Research North America, Cambridge, MA, United States.
Erina GhoshPhilips Research North America, Cambridge, MA, United States.
Dennis SwearingenDepartment of Medical Informatics, Banner Health, Phoenix, AZ, United States.
Joseph FrassicaInstitute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, United States.
Daniel McFarlanePhilips Research North America, Cambridge, MA, United States.
Bryan ConroyPhilips Research North America, Cambridge, MA, United States.
Philips (United States) · USMassachusetts Institute of Technology · USPhilips (India) · INUniversity of Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Healthcare-associated infection (HAI) remains a significant risk for hospitalized patients and a challenging burden for the healthcare system. This study presents a clinical decision support tool that can be used in clinical workflows to proactively engage secondary assessments of pre-symptomatic and at-risk infection patients, thereby enabling earlier diagnosis and treatment. Methods: This study applies machine learning, specifically ensemble-based boosted decision trees, on large retrospective hospital datasets to develop an infection risk score that predicts infection before obvious symptoms present. We extracted a stratified machine learning dataset of 36,782 healthcare-associated infection patients. The model leveraged vital signs, laboratory measurements and demographics to predict HAI before clinical suspicion, defined as the order of a microbiology test or administration of antibiotics. Results: Our best performing infection risk model achieves a cross-validated AUC of 0.88 at 1 h before clinical suspicion and maintains an AUC >0.85 for 48 h before suspicion by aggregating information across demographics and a set of 163 vital signs and laboratory measurements. A second model trained on a reduced feature space comprising demographics and the 36 most frequently measured vital signs and laboratory measurements can still achieve an AUC of 0.86 at 1 h before clinical suspicion. These results compare favorably against using temperature alone and clinical rules such as the quick sequential organ failure assessment (qSOFA) score. Along with the performance results, we also provide an analysis of model interpretability via feature importance rankings. Conclusion: The predictive model aggregates information from multiple physiological parameters such as vital signs and laboratory measurements to provide a continuous risk score of infection that can be deployed in hospitals to provide advance warning of patient deterioration.

Indexed as

clinical decision support (CDS)healthcare-associated infection (HAI)machine learningmodel interpretabilitypre-symptomatic infection risk

Identifiers

PMID38179280
PMCPMC10765581
OpenAlexW4389919299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.